Purpose: for the treatment of insulin dependent and non-insulin-dependent diabetes mellitus.
Properties
Summary
Acarbose is a new oral hypoglycemic drug. Competitive inhibition of glucoside hydrolase in the gut. It can reduce the decomposition of polysaccharide and sucrose into glucose, slow down the absorption of sugar, so it can reduce the postprandial blood glucose. Generally used alone, or with other oral hypoglycemic drugs, or insulin combined. Combined with catering to treat insulin dependent or non dependent diabetes mellitus.